133 related articles for article (PubMed ID: 10224338)
1. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
2. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Braga PC; Sasso MD; Sala MT
J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
[TBL] [Abstract][Full Text] [Related]
3. Effects of gatifloxacin on phagocytosis, intracellular killing and oxidant radical production by human polymorphonuclear neutrophils.
Braga PC; Dal Sasso M; Bovio C; Zavaroni E; Fonti E
Int J Antimicrob Agents; 2002 Mar; 19(3):183-7. PubMed ID: 11932139
[TBL] [Abstract][Full Text] [Related]
4. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
5. Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action.
Watanabe Y; Tawara S; Mine Y; Kikuchi H; Goto S; Kuwahara S
J Antibiot (Tokyo); 1986 Feb; 39(2):294-303. PubMed ID: 3514564
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
8. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
Labro MT; Amit N; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.
Braga PC; Sala MT; Dal Sasso M
Antimicrob Agents Chemother; 1999 May; 43(5):1013-9. PubMed ID: 10223908
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
Braga PC; Sala MT; Mancini L; Da Sasso M
Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
[TBL] [Abstract][Full Text] [Related]
11. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
Nomura S; Kuroiwa A; Murata K; Nagayama A
Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
13. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
[TBL] [Abstract][Full Text] [Related]
14. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
Pruul H; McDonald PJ
Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
16. Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation.
Bialasiewicz P; Stolarek R; Wejner P; Piasecka G; Dutkiewicz B; Mikucki J; Nowak D
Int J Immunopharmacol; 2000 Jul; 22(7):557-66. PubMed ID: 10785552
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effects of ceftibuten on the host defense mechanism.
Braga PC; Piatti G; Dal Sasso M; Maci S; Blasi F
Chemotherapy; 1994; 40(1):37-41. PubMed ID: 8306814
[TBL] [Abstract][Full Text] [Related]
18. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Murgia R; Marchetti F; Cinco M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
